Enalapril/hydrochlorothiazide
Подписчиков: 0, рейтинг: 0
| Combination of | |
|---|---|
| Enalapril | ACE inhibitor |
| Hydrochlorothiazide | Thiazide diuretic |
| Clinical data | |
| Trade names | Vaseretic, others |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a601047 |
| License data | |
| Pregnancy category |
|
| Routes of administration |
By mouth |
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| KEGG | |
Enalapril/hydrochlorothiazide, sold under the brand name Vaseretic among others, is a fixed-dose combination medication used for the treatment of hypertension (high blood pressure). It contains enalapril, an angiotensin converting enzyme inhibitor, and hydrochlorothiazide a diuretic. It is taken by mouth.
The most frequent side effects include dizziness, headache, fatigue, and cough.
History
Enalapril/hydrochlorothiazide was approved for medical use in the United States in October 1986.
Further reading
- Frishman WH, Goldberger J, Sherman D (December 1987). "Enalapril, hydrochlorothiazide, and combination therapy in patients with moderate hypertension". J Clin Hypertens. 3 (4): 520–7. PMID 2839628.
External links
- "Enalapril". Drug Information Portal. U.S. National Library of Medicine.
- "Hydrochlorothiazide". Drug Information Portal. U.S. National Library of Medicine.
|
ACE inhibitors ("-pril") |
|
|---|---|
|
AIIRAs ("-sartan") |
|
|
Renin inhibitors ("-kiren") |
|
| Dual ACE/NEP inhibitors | |
| Neprilysin inhibitors | |
| |
|
Sulfonamides (and etacrynic acid) |
|
||||||||
|---|---|---|---|---|---|---|---|---|---|
| Potassium-sparing (at CD) |
|
||||||||
| Osmotic diuretics (PT, DL) | |||||||||
|
Vasopressin receptor inhibitors (DCT and CD) |
|||||||||
| Other | |||||||||
| Combination products | |||||||||
| |||||||||